Table 2.
Number (%) of women with different histological classifications of endometrial tissue before treatment with continuous combined hormone replacement therapy
| Classification
|
Previous hormone replacement therapy
|
Total
|
||
|---|---|---|---|---|
| None (n=164)
|
Sequential (n=360)
|
Unopposed oestrogen (n=10)
|
||
| Unassessable | 76 (46) | 45 (13) | 5 (50) | 126 (24) |
| Inactive or atrophic | 68 (41) | 32 (9) | 0 (0) | 100 (19) |
| Proliferative | 3 (2) | 62 (17) | 1 (10) | 66 (12) |
| Secretory | 14 (9) | 180 (50) | 3 (30) | 197 (37) |
| Pseudo-decidual | 0 | 4 (1) | 0 | 4 (1) |
| Menstrual | 0 | 6 (2) | 0 | 6 (1) |
| Complex hyperplasia | 0 | 21 (6) | 1 (10) | 22 (4) |
| Atypical hyperplasia | 0 | 0 | 0 | 0 |
| Carcinoma | 0 | 0 | 0 | 0 |
| Other | 2 (1) | 8 (2) | 0 | 10 (2) |
| Missing | 1 (1) | 2 (1) | 0 | 3 (1)* |
*
Includes two patients who completed the follow up study and one patient who was withdrawn.